0001246360-13-003818.txt : 20130802
0001246360-13-003818.hdr.sgml : 20130802
20130802174917
ACCESSION NUMBER: 0001246360-13-003818
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130801
FILED AS OF DATE: 20130802
DATE AS OF CHANGE: 20130802
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ASPEN TECHNOLOGY INC /DE/
CENTRAL INDEX KEY: 0000929940
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING SERVICES [7371]
IRS NUMBER: 042739697
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 200 WHEELER ROAD
CITY: BURLINGTON
STATE: MA
ZIP: 01803
BUSINESS PHONE: 6179491000
MAIL ADDRESS:
STREET 1: 200 WHEELER ROAD
CITY: BURLINGTON
STATE: MA
ZIP: 01803
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MCARDLE JOAN C
CENTRAL INDEX KEY: 0001251386
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34630
FILM NUMBER: 131007561
4
1
form.xml
PRIMARY DOCUMENT
X0306
4
2013-08-01
false
0000929940
ASPEN TECHNOLOGY INC /DE/
AZPN
0001251386
MCARDLE JOAN C
ASPEN TECHNOLOGY, INC.
200 WHEELER ROAD
BURLINGTON
MA
01803
true
false
false
false
Common Stock
60000
I
By employer
Common Stock
2013-08-01
4
A
false
2727
0
A
22064
D
Director Stock Option (Right to Buy)
32.54
2013-08-01
4
A
false
3496
0
A
2023-07-31
Common Stock
3496
3496
D
These securities are held by Massachusetts Capital Resource Company. The reporting person serves as a senior vice president of Massachusetts Capital Resource Company, and may be deemed to have shared voting power over these securities. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Each Restricted Stock Unit represents a contingent right to receive one share of Aspen Technology, Inc. common stock. The Restricted Stock Units were fully vested on the date of grant.
Restricted Stock Units do not have an exercise price.
The option granted at the exercise price of $32.54 was fully vested on the date of grant.
/s/ F.G. Hammond, Attorney-In-Fact
2013-08-02